Home About Us FAQ Policies Contact Site Map

Advances in Apoptosis Research

Product Type: Market Research Report Publication Date: Mar 31, 2008
 
Request a sample from "The Infoshop", another service of Global Information.

SUMMARY

This research service provides the latest trends in apoptosis research and future developments

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • Scope and Methodology
    • Scope of the Research Service
    • Research Methodology
  • Insights into Apoptosis
    • Apoptosis and its Relevance in Therapeutics Industry
    • Key Industry Trends in Apoptosis

2 TECHNICAL FOCUS ON APOPTOSIS PHENOMENON

  • Apoptosis Molecular Pathways Exploration
    • Key Categories of Molecular Pathway Proteins
    • Understanding the Role of Apoptosis Proteins
  • Apoptosis Correlated Therapeutic fields
    • Apoptosis Functioning in Cancer Treatment
    • Apoptosis Basis Connected with Neurodegenerative and Cardiovascular Diseases
  • Other Cell Apoptosis-Centered Disorders
    • Organ Transplantation-Associated Syndromes
    • HIV and Cell Sepsis Controlled by Apoptosis
  • Apoptosis Identification Techniques
    • Diagnosis and Analyzing Apoptosis In Vivo
    • Potential Markers for Apoptosis Recognition

3 ASSESSMENT OF NOTABLE TECHNOLOGIES INVOLVED IN DRUG DISCOVERY FOR APOPTOSIS-BASED TREATMENT

  • Highlights of Key Developments in the North American region.
    • Triggering Apoptosis:Innovative Oncology Drug Discovery Platform
    • Broad Range of Clinical Development Compounds for the Treatment of Advanced Solid Tumors
    • Promising Small Molecule Investigational Drugs Targeting Malignancies
    • Novel Cancer Therapies Targeting Treatment Resistance in Oncology Patients
    • Tumor-Targeting Antibodies Delivering Potent Cell-Killing Agents
    • Cell Cycle Inhibitors Work on Cancer through Apoptosis
    • Medical Device Employs Apoptosis to Reduce Cardiac Inflammation
    • BCL-2 Emerges as a Hot Target for Cancer Therapeutics
  • Notable Developments in the Rest of the World
    • Unique Anticancer Therapeutics Targeting Cell Death Pathways
    • Novel Small Molecules Product Targeting Established Tumor Blood Vessels
    • Potential Treatment Paradigm Designed for the Treatment of Solid Tumors
    • Pioneering Oligonucleotide-Based Drugs Targeting Malignant Tumors
    • Promising Drug Development Platform with Broad Oncology Applications
    • Advancements in Progressive Functional Pathways Studies Critical to Cancer Cells Growth
    • Novel Class of Clinical-Stage Tumor Growth-Reducing Cancer Therapeutics
    • Novel Drug Therapy for Treating Solid Tumors and Blood Cancer
    • Highly Targeted and Potent Antiangiogenic Cancer Therapy
  • Universities Advancements
    • Miniature Stage Biomarker-Focused Translational Research
    • Novel Research Findings Identifying Combination Therapy for Cancer
    • Innovative Research Findings Exploiting Oncolytic Virus Therapy for Cancer Treatment

4 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Drivers and Challenges Involved in Apoptosis Treatment
    • Notable Drivers
    • Challenges and Restraints
  • Patent Assessment and Analyst Insights
    • Patent Assessment
    • Analyst's Perspective and Futuristic Trends
    • Entry and Expansion Strategies

5 PATENT STUDY AND DATABASE OF KEY PARTICIPANTS.

  • Patents Review
    • Corporate Patents
    • Academic Patents
  • Main Participants
    • Companies
    • Universities

6 DECISION SUPPORT DATABASE

  • Database Tables
    • World R&D Expenditure
    • World Healthcare Expenditure (2002 to 2012)
    • Mortality of Bladder Cancer--World (2002 to 2012)
    • Incidence of Bladder Cancer--World (2002 to 2012)
    • Number of Active Physicians (2002 to 2012)

Advances in Apoptosis Research

Publisher: Technical Insights, Inc.

Format Price Order
Web Access (Regional License) US $6000.00
Hard Copy & Web Access (Regional License) US $6500.00
All orders are processed by "www.the-infoshop.com". www.the-infoshop.com is another Global Information web site. This transfer is entirely safe.
Copyright© 2008 GII - All Rights Reserved.